194 related articles for article (PubMed ID: 23073207)
1. Drug labels: a flawed source of data for studying orphan drug approvals.
Kesselheim AS; Avorn J
Clin Pharmacol Ther; 2012 Dec; 92(6):694; author reply 695. PubMed ID: 23073207
[No Abstract] [Full Text] [Related]
2. Raising orphans: how clinical development programs of drugs for rare and common diseases are different.
Orfali M; Feldman L; Bhattacharjee V; Harkins P; Kadam S; Lo C; Ravi M; Shringarpure DT; Mardekian J; Cassino C; Coté T
Clin Pharmacol Ther; 2012 Aug; 92(2):262-4. PubMed ID: 22739137
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis to guide orphan drug development.
Lesko LJ
Clin Pharmacol Ther; 2012 Aug; 92(2):258-61. PubMed ID: 22739138
[TBL] [Abstract][Full Text] [Related]
4. Accelerating orphan drug development.
Coté TR; Xu K; Pariser AR
Nat Rev Drug Discov; 2010 Dec; 9(12):901-2. PubMed ID: 21119719
[TBL] [Abstract][Full Text] [Related]
5. Medicines for rare (orphan) diseases: an enquiry and proposal for tax-incentives.
John JE
Drug Discov Today; 2011 Dec; 16(23-24):999-1000. PubMed ID: 22020052
[No Abstract] [Full Text] [Related]
6. Flexibility in the FDA approach to orphan drug development.
Hunter NL; Rao GR; Sherman RE
Nat Rev Drug Discov; 2017 Nov; 16(11):737-738. PubMed ID: 28860647
[No Abstract] [Full Text] [Related]
7. An aide memoire for model-based drug development--a new key for the interpretation of the erythromycin breath test--therapeutic index as a biomarker for smart drug development.
Boutouyrie-Dumont B
Biomark Med; 2013 Feb; 7(1):89-91. PubMed ID: 23387489
[No Abstract] [Full Text] [Related]
8. A human-on-a-chip approach to tackling rare diseases.
de Mello CPP; Rumsey J; Slaughter V; Hickman JJ
Drug Discov Today; 2019 Nov; 24(11):2139-2151. PubMed ID: 31412288
[TBL] [Abstract][Full Text] [Related]
9. [The stakes of pre- and post-market authorization development and clinical assessment].
Schwebig A
Presse Med; 2012 May; 41 Suppl 1():S6-8. PubMed ID: 22483770
[No Abstract] [Full Text] [Related]
10. Crafting a robust business model for orphan drug development.
Philippidis A
Hum Gene Ther; 2011 Jul; 22(7):781-3. PubMed ID: 21756074
[No Abstract] [Full Text] [Related]
11. Challenges and Hurdles to Business as Usual in Drug Development for Treatment of Rare Diseases.
Swinney DC
Clin Pharmacol Ther; 2016 Oct; 100(4):339-41. PubMed ID: 27393380
[TBL] [Abstract][Full Text] [Related]
12. Don't Do Different Things…Do Things Differently! Drug Development in Rare Diseases.
Rudek MA; Korth-Bradley JM
Clin Pharmacol Ther; 2016 Oct; 100(4):333-5. PubMed ID: 27393720
[TBL] [Abstract][Full Text] [Related]
13. FDA program could boost treatments for neglected diseases.
Traynor K
Am J Health Syst Pharm; 2008 Sep; 65(17):1595-6. PubMed ID: 18714098
[No Abstract] [Full Text] [Related]
14. Rare diseases and orphan drugs.
Melnikova I
Nat Rev Drug Discov; 2012 Mar; 11(4):267-8. PubMed ID: 22460117
[No Abstract] [Full Text] [Related]
15. A personal perspective of orphan drug development for rare diseases: A golden opportunity or an unsustainable future?
Oo C; Rusch LM
J Clin Pharmacol; 2016 Mar; 56(3):257-9. PubMed ID: 26211513
[No Abstract] [Full Text] [Related]
16. [Orphan drugs : New opportunities for the treatment of rare diseases].
Beck M
Internist (Berl); 2016 Nov; 57(11):1132-1138. PubMed ID: 27527064
[TBL] [Abstract][Full Text] [Related]
17. Orphan drug designation and development in Japan: 25 years of experience and assessment.
Sakushima K; Takeda H; Aoi Y
Nat Rev Drug Discov; 2021 Dec; 20(12):893-894. PubMed ID: 33723413
[No Abstract] [Full Text] [Related]
18. [Orphan drugs: drugs for rare diseases].
Schenk M
Dtsch Med Wochenschr; 2010 May; 135(18):p17. PubMed ID: 20455291
[No Abstract] [Full Text] [Related]
19. Innovative design and analysis for rare disease drug development.
Chow SC; Huang Z
J Biopharm Stat; 2020 May; 30(3):537-549. PubMed ID: 32065047
[TBL] [Abstract][Full Text] [Related]
20. A clinical pharmacology-regulatory perspective on the approval of drugs for rare diseases.
Bashaw ED
Clin Pharmacol Ther; 2016 Oct; 100(4):327-9. PubMed ID: 27417549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
